A prospective randomized trial comparing retrograde warm blood cardiop
legia with cold oxygenated crystalloid cardioplegia in coronary bypass
patients at Emery University revealed an increased risk of adverse ne
urological events in the warm group (4.5% vs 1.4%, p < 0.005). Multiva
riant analysis found four variables to be independent predictors of ad
verse neurological outcome: congestive heart failure (p = 0.002); age
(p = 0.002); aortic cross-clamp time (p = 0.02); and randomization to
the warm group (p = 0.026). In Toronto, a prospective randomized trial
compared antegrade warm blood cardioplegia with antegrade cold blood
cardioplegia. Compared to the Emery trial, the Toronto series containe
d fewer female patients (16% vs 25%), fewer patients older than age 70
(16% vs 30%), and fewer redo operations (4% vs 14%). The other promin
ent differences between the Emery series and the Toronto series were:
extensive use of retrograde cardioplegia in the Emery series; mild hyp
othermia in the warm group in the Toronto series; and elevated serum g
lucose in the warm group in the Emery series. The Toronto series showe
d no difference in adverse neurological events comparing cold versus w
arm cardioplegia groups. A comparison of these two series suggests tha
t mild hypothermia in the Toronto series, elevated glucose in the Emer
y series, or the use of retrograde cardioplegia may be operative in th
e elevated incidence of adverse neurological events seen in the Emery
series in addition to a relatively larger number of highrisk patients
(female, elderly, and redo) in the Emery series.